Skip to Content Skip to Content

Medicine

Reset All Filters
1649 Results
Researchers discover test to predict which patients with rare blood disease will respond to only FDA-approved treatment, and identify alternative therapy

Researchers discover test to predict which patients with rare blood disease will respond to only FDA-approved treatment, and identify alternative therapy

David Fajgenbaum and Sheila Pierson of the Perelman School of Medicine discuss their latest research and findings in the treatment of Castleman disease.

A new approach to determining post-acute care for older adults with dementia
Young person with hands on the shoulders of an older person, both wearing face masks.

A new approach to determining post-acute care for older adults with dementia

Two new studies measure the outcomes of home health care versus a skilled nursing facility for patients with dementia after being discharged in hospitals, and find that the mental status at the time of discharge is more relevant than a dementia diagnosis.

From Penn LDI

New program inspires underrepresented young women to cancer research
Screen capture of 11 participants in a Zoom call.

The Abramson Cancer Center’s Summer Health Experience, or SHE program, exposes students like Bintou Samassa (bottom left) to a career in cancer research. (Image: Penn Medicine News)

New program inspires underrepresented young women to cancer research

The Abramson Cancer Center’s Summer Health Experience, or SHE, program introduces young women to careers in cancer research. Statistics show that Black and Latinx women are severely underrepresented in the health sciences.

Steve Graff

Restoring ‘chaperone’ protein may prevent plaque buildup in Alzheimer’s
Microscopic image of cancer proteins.

DAXX (red color at top) prevents the aggregation of mutant p53 protein associated with cancers (dark green color at bottom) in cells. (Image: Penn Medicine News)

Restoring ‘chaperone’ protein may prevent plaque buildup in Alzheimer’s

Penn Medicine researchers show how restoring levels of the protein DAXX and a large group of similar proteins prevents the misfolding of the rogue proteins known to drive Alzheimer’s and other neurodegenerative diseases.

From Penn Medicine News